Other languages Accolade, Inc.

Equities

ACCD

US00437E1029

Real-time Estimate Cboe BZX Other stock markets 09:08:12 03/05/2024 pm IST			5-day change	1st Jan Change
7.5 ^USD	+3.31%		-4.82%	-37.47%

30/04	Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating	MT
26/04	Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Accolade, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended February 29, 2024	26/04
Accolade, Inc. Promotes Kelsi McDonald Harris to Chief People Officer and Senior Vice President	19/03
Accolade Insider Sold Shares Worth $1,554,504, According to a Recent SEC Filing	12/01
Accolade Shares Surge After Raymond James Upgrade, Fiscal Q3 Results	10/01
Accolade Fiscal Q3 Loss Halves, Sales Jump; Issues Guidance	09/01
Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ending February 29, 2024 and Year Ending February 28, 2025	09/01
Accolade, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023	09/01
Accolade to Repurchase $76.5 Million of Outstanding Debt	17/11
U.S. employers covering weight-loss drugs could nearly double in 2024 - survey	10/23/10
Accolade Reports Narrowing Net Loss in Fiscal Q2 as Sales Increase	05/23/05
Accolade, Inc. Provides Earnings Guidance for the Third Quarter and Full Fiscal Year 2024	05/23/05
Accolade, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023	05/23/05
Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience	18/23/18
MÄRKTE USA/Fester nach ermutigenden Preisdaten	01/23/01
MÄRKTE USA/Fester - Preisdaten befeuern Kauflust	30/23/30
MÄRKTE USA/Freundlich - Preisdaten sorgen für Kauflaune	30/23/30
Sector Update: Health Care Stocks Advance Premarket Friday	30/23/30
MÄRKTE USA/PCE-Deflator untermauert gute Stimmung	30/23/30
Accolade Fiscal Q1 Loss Narrows as Revenue Rises; Lifts Fiscal 2024 Revenue Guidance; Shares Surge Premarket	30/23/30
MARKT USA/Fester erwartet - PCE-Deflator sorgt für Spannung	30/23/30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Accolade, Inc.

Equities

ACCD

US00437E1029

Other languages

Filters